(R)-4-Methyloxazolidin-2-one → HCID 71251935, compound

HRID 2412022Notes

Reaction equation

HRID 2412022 reaction equation
Br[C:2]1[N:3]=[CH:4][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH:23]4[CH2:25][CH2:24]4)=[CH:18][N:17]=3)[CH2:12][CH2:11]2)=[O:9])=[N:6][CH:7]=1.[CH3:26][C@@H:27]1[CH2:31][O:30][C:29](=[O:32])[NH:28]1>>[CH:23]1([C:19]2[CH:20]=[C:21]([CH3:22])[C:16]([N:13]3[CH2:14][CH2:15][N:10]([C:8]([C:5]4[N:6]=[CH:7][C:2]([N:28]5[C@H:27]([CH3:26])[CH2:31][O:30][C:29]5=[O:32])=[N:3][CH:4]=4)=[O:9])[CH2:11][CH2:12]3)=[N:17][CH:18]=2)[CH2:25][CH2:24]1

Participants

3

Reactant 2

HCID 2734858(R)-4-Methyloxazolidin-2-oneHCID 86676769HCID 86676769, compound

Product 1

HCID 71251935HCID 71251935, compoundYield 16.9%

Procedure

Using (5-bromopyrazin-2-yl)[4-(5-cyclopropyl-3-methylpyridin-2-yl)piperazin-1-yl]methanone (175 mg) described in Preparation Example 243 and (R)-4-methyloxazolidin-2-one (53 mg) and by the reaction and treatment in the same manner as in Example 1, the title compound (31 mg) was obtained.

Sources & evidence

ORD record
ord-e40041adce2b4d99aad53dd14648fe91
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…